Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Genpact Ltd shares valued at $703,855 were sold by Dewan Sameer on Jan 13 ’26. At $46.65 per share, Dewan Sameer sold 15,088 shares. The insider’s holdings dropped to 37,749 shares worth approximately $1.79 million following the completion of this transaction.
Also, Vashisht Riju sold 16,016 shares, netting a total of over 747,146 in proceeds. Following the sale of shares at $46.65 each, the insider now holds 95,521 shares.
Before that, HEATHER D WHITE had added 10,740 shares to its account. In a trade valued at $500,964, the Officer bought Genpact Ltd shares for $46.64 each.
As published in their initiating research note from Susquehanna on December 12, 2025, Genpact Ltd [G] has been a Neutral and the price target has been revised to $50. Analysts at Citigroup started covering the stock with ‘”a Neutral”‘ outlook in a report released in late October. Earlier on February 07, 2025, TD Cowen upgraded its rating. Their new recommendation was “a Buy” for G stock which previously was a “a Hold”.
Analyzing G Stock Performance
On last trading session, Genpact Ltd [NYSE: G] rose 1.98% to $47.44. The stock’s lowest price that day was $46.52, but it reached a high of $47.91 in the same session. During the last five days, there has been a surge of approximately 0.08%. Over the course of the year, Genpact Ltd shares have jumped approximately 7.06%.
Is Genpact Ltd subject to short interest?
Stocks of Genpact Ltd saw a sharp steep in short interest on 2025-12-31 dropping by -0.64 million shares to 6.5 million. Data from Yahoo Finance shows that the short interest on 2025-11-28 was 7.14 million shares. A decline of -9.79% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 4.15 of the overall float, the days-to-cover ratio (short ratio) decline to 4.15.
Which companies own the most shares of Genpact Ltd (G)?
In terms of Genpact Ltd share price expectations, FactSet research, analysts set an average price target of 51.5 in the next 12 months, up nearly 10.71% from the previous closing price of $46.52. Analysts anticipate Genpact Ltd stock to reach 53 by 2026, with the lowest price target being 50. In spite of this, 6 analysts ranked Genpact Ltd stock as Hold at the end of 2026. On January 21, 2025, Jefferies assigned a price target of “a Buy” to the stock and upgraded coverage with a $55.
